Human U3 protein14a is a novel type ubiquitin ligase that binds RB and promotes RB degradation depending on a leucine-rich region-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Human U3 protein14a is a novel type ubiquitin ligase that binds RB and promotes RB degradation depending on a leucine-rich region

Published:2018-11 Issue:11 Volume:1865 Page:1611-1620
ISSN:0167-4889
Container-title:Biochimica et Biophysica Acta (BBA) - Molecular Cell Research
language:en
Short-container-title:Biochimica et Biophysica Acta (BBA) - Molecular Cell Research

Author:

Liu Huijiao,Wang Jiangnan,Liu Yun,Hu Lelin,Zhang Chunfeng,Xing Baocai,Du Xiaojuan

Funder

National Natural Science Foundation of China

973 Program

Innovation Team of Ministry of Education

Publisher

Elsevier BV

Subject

Cell Biology,Molecular Biology

Reference58 articles.

1. The transcriptional transactivation function of wild-type p53 is inhibited by SV40 large T-antigen and by HPV-16 E6 oncoprotein;Mietz;EMBO J.,1992

2. The Rb gene and the negative regulation of cell growth;Weinberg;Blood,1989

3. The HIP1 binding site is required for growth regulation of the dihydrofolate reductase gene promoter;Means;Mol. Cell. Biol.,1992

4. Cell cycle regulation of the murine cyclin E gene depends on an E2F binding site in the promoter;Botz;Mol. Cell. Biol.,1996

5. Cyclin A expression is under negative transcriptional control during the cell cycle;Huet;Mol. Cell. Biol.,1996

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Genome-wide in vivo CRISPR screen identifies TGFβ3 as actionable biomarker of palbociclib resistance in triple negative breast cancer;Molecular Cancer;2024-06-03

2. The G1/S transition is promoted by Rb degradation via the E3 ligase UBR5;2023-10-04

3. Post-translational modifications on the retinoblastoma protein;Journal of Biomedical Science;2022-06-01

4. Protein post-translational modifications in the regulation of cancer hallmarks;Cancer Gene Therapy;2022-04-07

5. Cyclin F drives proliferation through SCF-dependent degradation of the retinoblastoma-like tumor suppressor p130/RBL2;ELIFE;2021

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3